Q2
APYX — Q2 2026 Financial Report Analysis
Apyx Medical's Q2 2026 sales rose 22.1% to $13.9M as AYON drove 28% Surgical Aesthetics growth, narrowing the operating loss to $1.8M, but FY2026 guidance implies a much slower second half and leaves little room on its loan covenant.